A Novel Drosophila-based Drug Repurposing Platform Identified Fingolimod As a Potential Therapeutic for TDP-43 Proteinopathy
Pathogenic changes to TAR DNA-binding protein 43 (TDP-43) leading to alteration of its homeostasis are a common feature shared by several progressive neurodegenerative diseases for which there is no effective therapy. Here, we developed Drosophila lines expressing either wild type TDP-43 (WT) or tha...
Saved in:
Main Author: | Lo Piccolo L. |
---|---|
Other Authors: | Mahidol University |
Format: | Article |
Published: |
2023
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/88198 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Wild type human TDP-43 potentiates ALS-linked mutant TDP-43 driven progressive motor and cortical neuron degeneration with pathological features of ALS
by: Mitchell, J.C, et al.
Published: (2020) -
MOLECULAR MECHANISMS OF TDP-43 MEDIATED NEURODEGENERATION
by: WANG LU
Published: (2020) -
A pharmacometric approach to evaluate drugs for potential repurposing as COVID-19 therapeutics
by: Wattanakul T.
Published: (2023) -
UNDERSTANDING THE INFLUENCE OF TDP-43 LOSS-OF-FUNCTION ON NEUROTROPHIN SIGNALLING
by: TANN YONG YOU, JASON
Published: (2018) -
Roles of TDP-43 domains in RNA-free phase separation
by: Sim, Dynn
Published: (2022)